In 2025, Poly Medicure completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Poly Medicure has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 3,337.95a | 2,319.85a | 3,110b | |
Total Scope 2 | ||||
Unspecified Calculation Method | 40,088.73a | 33,962.28a | 30,230b | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 17.0794a | 14.0616a | 22.8951b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Poly Medicure amounted to 43,426.68 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Poly Medicure increased by 19.69%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2025, the total Scope 1 emissions of Poly Medicure were 3,337.95 metric tons of CO₂ equivalent (tCO₂e).a
Since 2022, Poly Medicure's Scope 1 emissions have increased by 48.35%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2024), Poly Medicure's Scope 1 emissions increased by 43.89%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Poly Medicure reported Scope 2 greenhouse gas (GHG) emissions of 40,088.73 tCO₂e without specifying the calculation method.a
Since 2022, Poly Medicure's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 60.61%, reflecting a rising long-term trend in Scope 2 emissions over time.ab
Compared to the previous year (2024), Poly Medicure's Scope 2 emissions (Unspecified Calculation Method) rose by 18.04% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2025, Poly Medicure reported its Scope 2 emissions using an unspecified methodology.a
In 2025, Poly Medicure reported Scope 1 greenhouse gas (GHG) emissions of 3,337.95 tCO₂e and total revenues of USD 195 millions. This translates into an emissions intensity of 17.08 tCO₂e per millions USD.a
In 2025, Poly Medicure reported a Scope 1 emissions intensity of 17.08 tCO₂e per millions USD. Compared to the peer group median of 4.33, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2025, Poly Medicure ranked 23 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Poly Medicure among the least efficient performers, with one of the highest emissions intensities in its sector.a